SCHEMBL10478117

SCHEMBL10478117

O=C(O)c1c[nH]c2ccc(F)c(Cl)c2c1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.56
HSD17B10 Q99714 2/20 0.56
KDM4E B2RXH2 1/20 0.52
F7 P08709 1/20 0.50
F3 P13726 1/20 0.50
CSNK2A2 P19784 3/20 0.49
CSNK2B P67870 3/20 0.49
CSNK2A1 P68400 3/20 0.49
HPGD P15428 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALOX12 P18054 1/20 0.43
KMT2A Q03164 1/20 0.43
HTT P42858 1/20 0.41
PRKAB2 O43741 2/20 0.41
PRKAG1 P54619 2/20 0.41
PRKAA2 P54646 2/20 0.41
PRKAA1 Q13131 2/20 0.41
PRKAG3 Q9UGI9 2/20 0.41
PRKAG2 Q9UGJ0 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17417762 0.89 F7 (0.54) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL10366861 0.82 HSD17B10 (0.56) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL10478138 0.80 GABRA1 (0.54) CYP1A2HSD17B10KDM4EHPGDMEN1
SCHEMBL2971998 0.78 CYP1A2 (0.55) CYP1A2HSD17B10KDM4ECSNK2A2CSNK2B
SCHEMBL15823151 0.76 P2RX7 (0.54) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL16597465 0.76 GPR84 (0.51) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL23622950 0.73 F7 (0.50) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL17417701 0.73 F7 (0.46) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL17417627 0.73 F7 (0.46) CYP1A2HSD17B10KDM4EF7F3
SCHEMBL31332322 0.73 GPR84 (0.46) F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4868305-A SEPARATION OF HALOGENATED ISOMERS BY SALT FORMATION AND CRYSTALLIZATION STERLING DRUG INC. (US) 1989-09-19 US claimed
US-4868305-A SEPARATION OF HALOGENATED ISOMERS BY SALT FORMATION AND CRYSTALLIZATION STERLING DRUG INC. (US) 1989-09-19 US disclosed